Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Fox (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Wiffen (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom). Is the strength of the type-2 (T2) inflammatory biomarker signal important in determining the burden of disease in severe asthma (SA)?. 1241

Member's Comments

No comment yet.

Related content which might interest you: Umeclidinium/vilanterol in preventing clinically important deterioration (CID) in COPD and impact of baseline disease severity: the EMAX trial Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The loss of the beneficial effect of deep inspiration (DI) in COPD is associated with severity of disease Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment Year: 2012 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 What are the factors associated with severity of occupational asthma (OA) at diagnosis? Source: Eur Respir J 2005; 26: Suppl. 49, 34s Year: 2005 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Fluctuations in airway function: chronic asthma seen as a complex dynamic system Source: Annual Congress 2006 - Physiological year in review Year: 2006 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD. Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005